National Health Investors, Inc.

NHI Real Estate Reit Healthcare Facilities

National Health Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $375.6 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 33.8%, EPS grew 45.6%, free cash flow grew 2,585.5% and total debt rose 13.9%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three; insiders bought in the last twelve months.

66.28 0.61 +0.93%
Market cap
$3.2B
P/E
19.1×
Fwd P/E
20.2×
Dividend yield
5.58%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

National Health Investors, Inc. (NHI) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, National Health Investors, Inc. (NHI) trades at a P/E ratio of 19.1×. Over the past ten years it has ranged from 8.9× (April 2020) to 46.0× (August 2022); the current reading is higher than 34% of that period. That is below the Reit Healthcare Facilities industry median of 23.0× and below the Real Estate sector median of 21.6×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 25.2× 14.20%
FY2024 22.1× 24.09%
FY2023 17.8× (50.51%)
FY2022 35.9× 52.58%
FY2021 23.6× 40.97%
FY2020 16.7× (24.54%)
FY2019 22.1× 8.16%
FY2018 20.5× 5.36%
FY2017 19.4× 1.10%
FY2016 19.2× 24.72%

Quarterly newest first

Period P/E ratio Change
Jun 2026 22.0× (15.47%)
Mar 2026 26.0× 3.16%
Dec 2025 25.2× 1.14%
Sep 2025 24.9× 12.31%
42 more quarters

Against its own ten years

Low 8.9× High 46.0×
Ten-year median 20.8×
Current reading's percentile 34

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on NHI